Browsing by Author "Flepisi, Brian"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Differential effects of normoxic versus hypoxic derived breast cancer paracrine factors on brain endothelial cells
    (MPDI, 2021) Rado, Mariam; Flepisi, Brian; Fisher, David
    The blood-brain barrier (BBB) is a central nervous system protective barrier formed primarily of endothelial cells that regulate the entry of substances and cells from entering the brain. However, the BBB integrity is disrupted in disease, including cancer, allowing toxic substances, molecules, and circulating cells to enter the brain. This study aimed to determine the mitochondrial changes in brain endothelial cells co-cultured with cancer cells. Method: Brain endothelial cells (bEnd.3) were co-cultivated with various concentrations of breast cancer (MCF7) conditioned media (CM) generated under normoxic (21% O2 ) and hypoxic conditions (5% O2 ). The mitochondrial activities (including; dehydrogenases activity, mitochondrial membrane potential (∆Ψm), and ATP generation) were measured using Polarstar Omega B.M.G-Plate reader. Trans-endothelial electrical resistance (TEER) was evaluated using the EVOM system, followed by quantifying gene expression of the endothelial tight junction (ETJs) using qPCR. Results: bEnd.3 cells had reduced cell viability after 72 h and 96 h exposure to MCF7CM under hypoxic and normoxic conditions.
  • Thumbnail Image
    Item
    The effect of sunitinib on neuroblastoma and glioblastoma cell growth
    (University of the Western Cape, 2020) Roos, Kelly; Hiss, Donavon; Flepisi, Brian
    Cancer is a global health catastrophe, with neuroblastoma, the most common solid childhood tumor, and glioblastoma, a deadly brain tumor, being aggressive and unresponsive to current treatment modalities. These tumors are known to utilize uncontrollable cell proliferative capabilities as a mechanism for tumor survival. Therefore, malignant cell growth can be mitigated by targeting the essential proteins that regulate cell growth, such as receptor tyrosine kinases (RTKs). Under normal physiological conditions, RTKs bind with varying affinity to mitogenic stimuli such as growth factors such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) which, in turn, leads to receptor phosphorylation and activation.